Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Cozaar
Active Ingredient(s): Losartan potassium 12.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Merck Sharp & Dohme UK Limited, Cramlington, Northumberland, United Kingdom
Product: Cozaar
Active Ingredient(s): Losartan potassium 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Merck Sharp & Dohme UK Limited, Cramlington, Northumberland, United Kingdom
Dated this 27th day of October, 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).